12:23 p.m., EST
Wells Fargo: Just the start?
The short answer is probably yes; but that’s only one problem.
Everyone’s subject to ‘normalcy bias‘ as Nissam Taleb puts it; Today’s like yesterday and tomorrow will be like today.
The news on Wells Fargo shows how quickly that can change.
Here’s a YouTube link; one man’s assessment on what happens now.
He proposes a ‘ripple effect’.
Events have been set in motion; not necessarily immediately but it has started nonetheless.
So, here we are going into the weekend.
Does anyone want to be long the market at this point (not advice, not a recommendation)?
There must be some that do as we’re still at elevated levels.
The trade approach implemented on this site (i.e., positioning short), takes into account and actually plans for a ‘disconnect’.
Only the inexperienced or naïve think (at this time in market history) they can get out as easily as they got in; i.e. day and swing trading.
Analysis: SPBIO (LABD):
We’ll start close in first and look at the hourly LABD:
Price action has come back to test the boundary (blue line).
As frustrating as it might seem (and it is), this is normal market behavior. The market itself has to define who is in control; bulls or bears.
It’s never ending.
That’s why a case has been built on the fundamental side; why biotech is subject to a massive implosion.
That backdrop, is being supported (little by little) with price action and thus, helps keep the mind focused.
If we pull out to the daily, we see the familiar trend-line(s):
We’re at another danger point. Price action can go either way.
If LABD pivots higher from here, it’s one more confirmation that we’re trending higher (SPBIO, lower) into our October-exit timeframe (not advice, not a recommendation).